.

Perrigo Ordinary Shares reported $4.12B in Debt for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Bayer BAYN:GR € 44634M 2087M
Bristol Myers Squibb BMY:US $ 42060M 2912M
Catalent CTLT:US $ 4202M 16M
Coherus Biosciences CHRS:US $ 196.04M 224.42M
Corcept Therapeutics CORT:US $ 0M 0M
Eli Lilly And LLY:US $ 16813.8M 305M
Endo International Ordinary Shares ENDP:US $ 8065.3M 25.32M
Horizon Pharma HZNP:US $ 2566.99M 1.75M
JAZZ PHA JAZZ:US $ 6021M 2.87M
Lannett LCI:US $ 614.95M 4.87M
Pacira Pharmaceuticals PCRX:US $ 755.65M 167.77M
Perrigo Ordinary Shares PRGO:US $ 4116.9M 601.7M
Phibro Animal Health PAHC:US $ 417.92M 2.3M
Prestige Brands PBH:US $ 1479M 4.91M
Supernus Pharmaceuticals SUPN:US $ 400.91M 0.53M
Teva Pharmaceutical TEVA:IT 22.08B 835M
Xeris Pharmaceuticals Inc XERS:US $ 138.07M 429K
Zoetis ZTS:US $ 6573M 5M